Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

OPHTHALMOLOGICAL INSTITUTE   OPHTALMOLOGICAL RESEARCH FOUNDATION   UNIVERSITY INSTITUTE   FERNÁNDEZ-VEGA FOUNDATION  Do we call you?
Welcome to MedicalPress a Premium Medical Theme
Title Image
You are in:  / Home  /  investigation

investigation

  RESEARCHER: Dr. Jesús Merayo Lloves  FINALIZADO    Efficacy and safety of T4020 versus its vehicle in patients with chronic neurotrophic keratitis or corneal ulcer. INDICATION: Patients with neurotrophic keratitis or neurotrophic corneal ulcer TREATMENT: Cacicol® PROMOTOR: Laboratoires THÉA

  RESEARCHER: Dr. Jesús Merayo Lloves  ACTIVO    A multicentre, randomized, double masked, 4-parallel, controlled, 6-month phase II study to assess the safety and efficacy of a cyclosporine PAD ophthalmic dispersion (0.06% and 0.03% CsA). Administered once daily in combination with lubricant therapy and safety

  RESEARCHER: Dr. Jesús Merayo Lloves  RECLUTANDO    "Double-blind, placebo-controlled phase I / II study to assess the efficiency and safety of AVX012 ophthalmic solution in subjects with mild to moderate dry eye" INDICATION: Pacientes con ojo seco leve o moderado TREATMENT: AVX-012 PROMOTOR: Avizorex Pharma

  RESEARCHER: Dr. Álvaro Fernández-Vega Sanz  ACTIVO    Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye. INDICATION: Patients with Macular Degeneration Associated with the

  RESEARCHER: Prof. Luis Fernández-Vega Sanz  RECLUTANDO    A dose-Ranging, Muti-Centre, Randmised, Double-Mased, Sham-Controlled, Parallel-Group Study of the Efficacy and safety of Opt-302 in Combination wiht Ranibizumab Compared with Ranibizumab Alone, in Patients with Neovascular Age-Related Macular Degeneration ( Wet AMD) INDICATION: Pacientes con degeneración macular

  RESEARCHER: Dr. Álvaro Fernández-Vega Sanz  ACTIVO    Phase IV, randomized, double-blind, simulated control study for the efficacy, safety, and tolerability of Aflibercept intravitreal monotherapy compared to Aflibercept and Concomitant Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy. (ATLANTIC) INDICATION: Patients with polypoid choroidal vasculopathy TREATMENT: Aflibercept PROMOTOR: AIBILI